• Je něco špatně v tomto záznamu ?

Use of gelatine capsules for application of methamphetamine: a new harm reduction approach

V. Mravčík, K. Skařupová, B. Orlíková, T. Zábranský, K. Karachaliou, B. Schulte,

. 2011 ; 22 (2) : 172-3. [pub] 20110115

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc12027873

BACKGROUND: In order to reduce injecting drug use, low-threshold facilities in the Czech Republic have started to distribute empty gelatine capsules as an oral alternative of drug application for those injecting methamphetamine. This report reviews implementation of this intervention and its possible benefits and limitations. METHODS: Between December 2008 and January 2009, 109 low-threshold facilities were asked to complete a questionnaire about the capsule programmes. Two focus groups were conducted, one with professionals involved in distribution and one with peer outreach workers who were interviewed on their experience of using the capsules. RESULTS: A total of 50 facilities (46%) responded to the questionnaire; 16 (32%) distributed the capsules regularly and 19 (38%) were planning to introduce this practice. The main target groups were injecting users of methamphetamine whose veins had been damaged, and methamphetamine users wishing to reduce injecting. The advantages of capsules, as perceived by service staff and peer outreach workers, were their easy use and the satisfactory effect of the oral application; health risks related to the oral use of methamphetamine were considered drawbacks. CONCLUSION: Capsule distribution is a promising harm reduction approach for injectors of methamphetamine or other stimulants; nonetheless its benefits and limitations should be further analysed in an in-depth longitudinal study.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12027873
003      
CZ-PrNML
005      
20230718142839.0
007      
ta
008      
120817s2011 ne f 000 0#eng||
009      
AR
024    7_
$a 10.1016/j.drugpo.2010.12.001 $2 doi
035    __
$a (PubMed)21242079
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Mravčík, Viktor $u The National Monitoring Centre for Drugs and Drug Addictions, Office of the Government of the Czech Republic, Czech Republic. mravcik.viktor@vlada.cz
245    10
$a Use of gelatine capsules for application of methamphetamine: a new harm reduction approach / $c V. Mravčík, K. Skařupová, B. Orlíková, T. Zábranský, K. Karachaliou, B. Schulte,
520    9_
$a BACKGROUND: In order to reduce injecting drug use, low-threshold facilities in the Czech Republic have started to distribute empty gelatine capsules as an oral alternative of drug application for those injecting methamphetamine. This report reviews implementation of this intervention and its possible benefits and limitations. METHODS: Between December 2008 and January 2009, 109 low-threshold facilities were asked to complete a questionnaire about the capsule programmes. Two focus groups were conducted, one with professionals involved in distribution and one with peer outreach workers who were interviewed on their experience of using the capsules. RESULTS: A total of 50 facilities (46%) responded to the questionnaire; 16 (32%) distributed the capsules regularly and 19 (38%) were planning to introduce this practice. The main target groups were injecting users of methamphetamine whose veins had been damaged, and methamphetamine users wishing to reduce injecting. The advantages of capsules, as perceived by service staff and peer outreach workers, were their easy use and the satisfactory effect of the oral application; health risks related to the oral use of methamphetamine were considered drawbacks. CONCLUSION: Capsule distribution is a promising harm reduction approach for injectors of methamphetamine or other stimulants; nonetheless its benefits and limitations should be further analysed in an in-depth longitudinal study.
650    _2
$a aplikace orální $7 D000284
650    _2
$a poruchy spojené s užíváním amfetaminu $x rehabilitace $7 D019969
650    _2
$a tobolky $7 D002214
650    _2
$a stimulanty centrálního nervového systému $x aplikace a dávkování $x škodlivé účinky $x chemie $7 D000697
650    _2
$a farmaceutická chemie $7 D002626
650    _2
$a příprava léků $7 D004339
650    _2
$a pomocné látky $x chemie $7 D005079
650    _2
$a zjišťování skupinových postojů $7 D017144
650    _2
$a želatina $x chemie $7 D005780
650    _2
$a snížení rizika poškození $7 D040261
650    _2
$a lidé $7 D006801
650    _2
$a injekce intravenózní $7 D007275
650    _2
$a methamfetamin $x aplikace a dávkování $x škodlivé účinky $x chemie $7 D008694
650    _2
$a hodnocení programu $7 D015397
650    _2
$a průzkumy a dotazníky $7 D011795
650    _2
$a intravenózní abúzus drog $x prevence a kontrola $7 D015819
651    _2
$a Česká republika $7 D018153
655    _2
$a časopisecké články $7 D016428
700    1_
$a Skařupová, Kateřina
700    1_
$a Orlíková, Barbora
700    1_
$a Zábranský, Tomáš, $d 1969-2021 $7 ola2003201138
700    1_
$a Karachaliou, Krystallia
700    1_
$a Schulte, Bernd
773    0_
$w MED00008614 $t The International journal on drug policy $x 1873-4758 $g Roč. 22, č. 2 (2011), s. 172-3
856    41
$u https://pubmed.ncbi.nlm.nih.gov/21242079 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m $z 0
990    __
$a 20120817 $b ABA008
991    __
$a 20230718142836 $b ABA008
999    __
$a ok $b bmc $g 949915 $s 785219
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2011 $b 22 $c 2 $d 172-3 $e 20110115 $i 1873-4758 $m The International journal on drug policy $n Int J Drug Policy $x MED00008614
LZP    __
$a Pubmed-20120817/11/03

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace